PubMed · 966636
[Decrease of disaccharidase activity following application of bencyclan-hydrogenfumarate (author's transl)].
Abstract
The disaccharidase activity of the small bowel mucosa of the rat is decreased by intraperitoneal application of Bencyclan-hydrogenfumarate. The doses applied were 10, 50 and 100 mg/kg body weight. The decrease rate after 100 mg/kg attained up to 50% of the control values. Furthermore, a reduction of villous height and an increase of the crypt depth has been observed in correlation with the enzyme activity decrease. Though functional and morphological alterations show a correlation, they cannot be explained by an antimetabolic-like effect because of the fact that the enzyme function recovers 72 h after application of the drug. Whilst our results do not sustain a cytostatic effect of Bencyclan-hydrogenfumarate, there is no doubt that the intraperitoneally applied drug influences the disaccharidase activity. These facts have to be considered in clinical therapy.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
H Frisius, H Al-Abadi, H Heidrich. 1976-09-15. [Decrease of disaccharidase activity following application of bencyclan-hydrogenfumarate (author's transl)].. https://doi.org/10.1007/bf01483592
Cite the original work for its findings. Save a collection to share your selection of sources.